Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MustGrow Biologics Corp V.MGRO

Alternate Symbol(s):  MGROF

MustGrow Biologics Corp. is a Canada-based agricultural biotechnology company. The Company is engaged in developing natural biological products derived from mustard seed to support sustainable farming. Its solutions provide alternatives to banned or restricted synthetic chemicals and fertilizers, promoting organic farming and soil health improvement. The Company develops mustard-based organic solutions for applications in biocontrol to potentially replace harmful synthetic chemicals in preplant soil treatment and weed control, to postharvest disease control and food preservation. Its TerraSante is Organic Materials Review Institute (OMRI Listed) and Organic Input Material (OIM) registered biofertility product in California, Florida, Arizona, Idaho, Oregon, and Washington. TerraSante provides mustard proteins and carbohydrates to feed the soil microbes. Its TerraMG is an organic plant extract from mustard used to help treat diseases and insect pests, such as nematodes.


TSXV:MGRO - Post by User

Post by Sportsfan82on Aug 04, 2021 10:35am
319 Views
Post# 33647951

Sumitomo News Release

Sumitomo News ReleaseNo way this company isn't bought out by a big AG company within the next year. Only thing you need to know from the news release. For the year ended March 31, 2021, Sumitomo Corporation had US$41.8 billion in annual revenue, US$5.4 billion of cash & cash equivalents and 957 consolidated subsidiaries & associated companies.
<< Previous
Bullboard Posts
Next >>